Skip to content
Screener

Axogen AXGN Stock-Based Comp

Stock-Based Comp at other companies

Baxter International logo
Baxter InternationalBAX
$10M0.0%
Stryker logo
StrykerSYK
$87M+3.6%
IAR
Integra LifeSciencesIART
$5.84M+10.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$1.94M-0.5%
Artivion logo
ArtivionAORT
$8.16M+33.4%
Bioventus logo
BioventusBVS
$5.04M+38.4%

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.38B+277%
Enterprise value$2.31B+242%
P/S9.5×+6.4×

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Axogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000805928-26-000094
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Change in fair value of debt derivative liabilities(322)
Investment gains, net(110)(121)
Loss on extinguishment of debt16,849
Stock-based compensation expense15,6098,077
Change in operating assets and liabilities:
Accounts receivable(7,905)(4,310)
Inventory(4,940)(3,591)
Prepaid expenses and other assets827(81)

ITEM 1 — FINANCIAL STATEMENTS

FAQ

What is Axogen's stock-based comp?
Axogen (AXGN) reported stock-based comp of $8.77M in Q2 2026.
How has Axogen's stock-based comp changed year-over-year?
Axogen's stock-based comp increased by 69.6% year-over-year, from $5.17M to $8.77M.
What is the long-term trend for Axogen's stock-based comp?
Over 4 years (2021 to 2025), Axogen's stock-based comp has grown at a 28.9% compound annual growth rate (CAGR), from $10.92M to $30.11M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Axogen's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude